Sponsor or institution
Clinical trials and research at Providence Health & Services - Oregon
As of November 12, 2026, Find a Trial lists 7 NIH-funded research projects at this institution, with $2.7 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7NIH research projects
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeting ARF6 and MAPK Pathways in Melanoma
This grant explores how melanoma cells use ARF6 and MAPK signaling to spread and resist treatment, with goals that could lead to new combination therapies for patients with this aggressive skin cancer.
-
Origins of tumor-reactive regulatory T cells in colorectal cancer patients
This grant explores how certain immune cells that can dampen anti-tumor responses (regulatory T cells) arise and behave in colon cancer, with the goal of understanding and potentially guiding better treatments for patients.
-
Improving radiation therapy by blocking TGFβ only inside tumors
This research tests whether blocking a protein called TGFβ only inside tumors can make radiation therapy work better for people with solid cancers.
-
Improving radiation treatment for cancer by targeting specific immune cells
This study is looking at how to make radiation therapy work better for cancer patients by focusing on special immune cells that help fight tumors, and it aims to find a way to block a certain protein in the tumor area to improve treatment results while keeping the immune system healthy elsewhere.
-
Stopping melanoma from growing and spreading by targeting key cell switches
This project tests ways to block molecular switches that make melanoma grow and resist treatment, aiming to help people with aggressive or treatment‑resistant melanoma.
-
Creating a new imaging tool to detect a cancer-related protein
This study is testing a new imaging tool that can help doctors see and measure a protein called TGFβ, which is important for understanding how cancer is behaving, and it's being tested in mice to see how well it works.
-
Investigating the roles of specific genes in the development and spread of soft tissue sarcomas.
This study is looking at how specific genes might play a role in the growth and spread of soft tissue sarcomas, which are rare and tough tumors, to help find better treatment options for patients like you.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.